Periscope Capital’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,182,558
Closed -$12.1M – 698
2023
Q2
$12.1M Buy
1,182,558
+72,756
+7% +$742K 0.94% 19
2023
Q1
$11.2M Buy
+1,109,802
New +$11.2M 0.52% 61

Periscope Capital's DALS Position: Q3 2023 in Review

Periscope Capital sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 1,182,558 shares — an estimated $12.1M sold.

Periscope Capital first reported a position in DALS in Q1 2023 and held it in 2 quarters. The position peaked at $12.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Periscope Capital reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Periscope Capital sold 1,182,558 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $12.1M.
  • Periscope Capital first reported a position in DA32 Life Science Tech Acquisition Corp in Q1 2023 and held it in 2 quarters.
  • Periscope Capital's DA32 Life Science Tech Acquisition Corp position peaked at $12.1M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Periscope Capital's 13F filing for Q3 2023, filed 6 Nov 2023.